| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 84.316 | - | 150.559 | 177.742 | 251.926 | 82.701 | 2.626 | 0 | 0 |
| Total Income - EUR | - | 88.506 | - | 149.885 | 177.766 | 251.935 | 82.705 | 2.626 | 0 | 0 |
| Total Expenses - EUR | - | 83.152 | - | 142.282 | 148.650 | 214.881 | 99.961 | 18.605 | 9.531 | 3.718 |
| Gross Profit/Loss - EUR | - | 5.354 | - | 7.603 | 29.116 | 37.053 | -17.256 | -15.980 | -9.531 | -3.718 |
| Net Profit/Loss - EUR | - | 4.511 | - | 6.097 | 27.338 | 34.534 | -18.083 | -16.058 | -9.531 | -3.718 |
| Employees | - | 8 | - | 6 | 5 | 6 | 6 | 0 | 0 | 0 |
Check the financial reports for the company - Cellprof Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 439 | - | 965 | 19.070 | 15.202 | 10.607 | 6.618 | 2.825 | 881 |
| Current Assets | - | 62.128 | - | 131.785 | 171.833 | 165.157 | 128.299 | 33.886 | 26.006 | 24.507 |
| Inventories | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 10.603 | - | 115.554 | 61.617 | 23.855 | 105.041 | 25.611 | 24.182 | 24.423 |
| Cash | - | 51.525 | - | 16.231 | 110.216 | 141.301 | 23.257 | 8.276 | 1.824 | 84 |
| Shareholders Funds | - | 4.577 | - | 33.849 | 60.532 | 46.566 | 21.264 | -74.871 | -84.175 | -87.422 |
| Social Capital | - | 67 | - | 67 | 65 | 64 | 63 | 63 | 63 | 62 |
| Debts | - | 57.989 | - | 98.901 | 130.371 | 133.794 | 117.642 | 115.375 | 113.006 | 112.810 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2829 - 2829" | |||||||||
| CAEN Financial Year |
2829
|
|||||||||
Comments - Cellprof Srl